Evidence map›Paper›PMID 34260637›Full record

ArticlePloS one2021

Implementation of an open-source robotic platform for SARS-CoV-2 testing by real-time RT-PCR.

José Luis Villanueva-Cañas, Eva Gonzalez-Roca, Aitor Gastaminza Unanue, Esther Titos, Miguel Julián Martínez Yoldi, Andrea Vergara Gómez, Joan Anton Puig-Butillé

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. High-throughput and automated screening for COVID-19.Frontiers in medical technology · 2022
    Review
  12. Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies.Diagnostics (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

José Luis Villanueva-CañasMolecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0001-7445-1267
Eva Gonzalez-RocaMolecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-1126-0321
Aitor Gastaminza UnanueIndependent engineer, Barcelona, Spain.ORCID 0000-0001-5333-8169
Esther TitosMolecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-2543-2243
Miguel Julián Martínez YoldiMolecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-0682-1075
Andrea Vergara GómezMolecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-5046-4490
Joan Anton Puig-ButilléMolecular Biology CORE (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0003-4345-9631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current global pandemic due to the SARS-CoV-2 has pushed the limits of global health systems across all aspects of clinical care, including laboratory diagnostics. Supply chain disruptions and rapidly-shifting markets have resulted in flash-scarcity of commercial laboratory reagents; this has motivated health care providers to search for alternative workflows to cope with the international increase in demand for SARS-CoV-2 testing. The aim of this study is to present a reproducible workflow for real time RT-PCR SARS-CoV-2 testing using OT-2 open-source liquid-handling robots (Opentrons, NY). We have developed a framework that includes a code template which is helpful for building different stand-alone robotic stations, capable of performing specific protocols. Such stations can be combined together to create a complex multi-stage workflow, from sample setup to real time RT-PCR. Using our open-source code, it is easy to create new stations or workflows from scratch, adapt existing templates to update the experimental protocols, or to fine-tune the code to fit specific needs. Using this framework, we developed the code for two different workflows and evaluated them using external quality assessment (EQA) samples from the European Molecular Genetics Quality Network (EMQN). The affordability of this platform makes automated SARS-CoV-2 PCR testing accessible for most laboratories and hospitals with qualified bioinformatics personnel. This platform also allows for flexibility, as it is not dependent on any specific commercial kit, and thus it can be quickly adapted to protocol changes, reagent, consumable shortages, or any other temporary material constraints.

Indexed as

Clinical CodingCOVID-19 Nucleic Acid TestingEarly DiagnosisHumansReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionRNA, ViralRoboticsSARS-CoV-2WorkflowRNA, Viral

Identifiers

PMID34260637
PMCPMC8279358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.